Lv11
58 积分 2022-09-14 加入
A Phase 2 Study of MORF-057, an Oral α4β7 Integrin Inhibitor in Moderately to Severely Active Ulcerative Colitis
4小时前
待确认
Pharmacokinetics, Safety, and Tolerability of GS‐1427, an Oral Prodrug of a Potent and Selective α4β7 Integrin Inhibitor, in Healthy Participants
4小时前
已完结
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers
28天前
已完结
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction
1个月前
已完结
[Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus (2025 edition)]
2个月前
已完结
Targeting Toll-like Receptors 7, 8, and 9 Inhibition in Systemic Lupus Erythematosus: Therapeutic Advance and Future Directions
2个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
2个月前
已完结
Liver-targeting chimeras as a potential modality for the treatment of liver diseases
3个月前
已完结
Development of ASGR-Mediated Hepatocyte-Targeting Cytotoxic Drug Conjugates with CTSB-Cleavable Linkers Incorporating Succinimide and Succinic Acid Monoamide
3个月前
已完结
STAT6 controls the stability and suppressive function of regulatory T cells
3个月前
已完结
皖公网安备34019202002308
